1. Atezolizumab plus vemurafenib and cobimetinib for the treatment of BRAF V600-mutant advanced melanoma: from an hypothetic triplet to an approved regimen. Issue 6 (2nd November 2021) Authors: Katsandris, Aikaterini; Ziogas, Dimitrios C.; Kontouri, Maria; Staikoglou, Stavroula; Gogas, Helen Journal: Expert review of precision medicine and drug development Issue: Volume 6:Issue 6(2021) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗